NL-OMON22827招募中不适用
Stop TPO-receptor agonist in ITP Patients
Haga Teaching Hospital, The Hague0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Chronic primary ITP
- •>18 years old
排除标准
- •Splenectomy in history
- •Secondary ITP
研究者
相似试验
已完成
4 期
Stop TPO-receptor agonist in ITP Patientsimmune trombocytopeniaITP1003553410003816NL-OMON54835Hagaziekenhuis40
招募中
3 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis - a double-blind, placebo-controlled trialK74K65R18K72K72.79R17A49K76.7Fibrosis and cirrhosis of liverAscitesHepatic failure, not elsewhere classifiedHyperbilirubinaemia, with or without jaundice, not elsewhere classifiedBacterial infection of unspecified sitePeritonitisHepatorenal syndromeDRKS00021290niversitätsklinikum Hamburg-Eppendorf476
招募中
4 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)2023-509863-26-00University Medical Center Hamburg-Eppendorf476
招募中
1 期
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)iver cirrhosisCTIS2023-509863-26-00niversity Medical Center Hamburg-Eppendorf476
已完成
不适用
Discontinuation of tyrosine kinase inhibitor treatment in patients who have obtained complete molecular response after treatment with tyrosine kinase inhibitors for chronic myeloid leukemiaChronic myeloid leukemiaJPRN-UMIN000004798Keio University School of Medicine, Division of Hematology70